Lithium tri-s-butylborohydride → HCID 178518596, Verbindung

To a stirred solution of 1,3-dihydro-1-{1-[4-oxocyclohex-1-yl]piperidin-4-yl}-2H-benzimidazol-2-one (100 mg) in dry tetrahydrofuran (25 mL) at -78° C., under nitrogen, was added L-Selectride (0.385 mL of a 1.0M solution in tetrahydrofuran). The reaction mixture was stirred at -78° C. for 30 min, then quenched with water (3 mL). The solution was allowed to warm to room temperature and ethyl acetate (50 mL) was added. The organic layer was washed with saturated sodium carbonate (10 mL), then water (10 mL), then brine (10 mL) and then dried over sodium sulfate. Concentration under reduced pressure yielded cis-1,3-dihydro-1-{1-[4-hydroxycyclohex-1-yl]piperidin-4-yl}-2H-benzimidazol-2-one (43 mg) as a colorless solid: 1H NMR (400 MHz, CD3OD) 7.42 (m, 1H), 7.05 (m, 3H), 4.32 (m, 1H), 3.94 (m, 1H), 3.17 (m, 2H), 2.53 (m, 5H), 1.88-1.71 (m, 8H), 1.59-1.53 (m, 2H). The hydrochloride salt was precipitated from diethyl ether/methylene chloride: analysis calculated for C18H25N3O2.HCl.0.70 H2O C: 59.48, H: 7.32, N: 11.56; found C: 59.46, H: 7.28, N: 11.23.

1. customquenched with water (3 mL)
2. temperatureto warm to room temperature
3. additionethyl acetate (50 mL) was added
4. washThe organic layer was washed with saturated sodium carbonate (10 mL)
5. dry with materialwater (10 mL), then brine (10 mL) and then dried over sodium sulfate
6. concentrationConcentration under reduced pressure

ORD-Eintrag

ord-80783b54fe8b444aad4f9665ef79e94f

Quelldatensatz

uspto-grants-1997_11

DOI

10.6084/m9.figshare.5104873.v1

Patentnummer

US05691323